Mammary tumors induced by human adenovirus type 9: A role for the viral early region 4 gene

Breast Cancer Research and Treatment

Volumn 39, Issue 1, 1996, Pages 57-67

  Javier, Ronald ^a   Shenk, Thomas ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b PRINCETON UNIVERSITY   (United States)

Author keywords

Ad9; Adenovirus; E4 region; Estrogen; Fibroadenoma; Mammary gland; ORF1; Phyllodes tumor

Indexed keywords

ESTROGEN; ONCOPROTEIN; TRANSFORMING PROTEIN; VIRUS DNA; VIRUS MESSENGER RNA; VIRUS PROTEIN;

ADENOVIRUS; ARTICLE; BREAST CARCINOGENESIS; BREAST SARCOMA; BREAST TUMOR; CYSTOSARCOMA PHYLLOIDES; FIBROADENOMA; HORMONAL REGULATION; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS CARCINOGENESIS; VIRUS CELL TRANSFORMATION; VIRUS DNA CELL DNA INTERACTION; VIRUS GENE;

ADENOVIRUSES, HUMAN; ANIMALS; BASE SEQUENCE; DNA, VIRAL; ESTROGENS; FEMALE; FIBROADENOMA; GENE EXPRESSION REGULATION, VIRAL; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, VIRAL; RATS; RATS, WISTAR; RNA, MESSENGER;

EID: 0029866370     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01806078     Document Type: Article

References (47)

1. Horwitz MS: Adenoviruses. In: Fields BN (ed) Virology. Raven Press, New York, 1990, pp 1723-1740
2. Horwitz MS: Adenoviridae and their replication. In: Fields BN (ed) Virology. Raven Press, New York, 1990, pp 1679-1721
3. Pereira HG, Huebner RJ, Ginsberg HS, Van Der Veen J: A short description of the adenovirus group. Virol 20:613-620, 1963
4. Green M, Mackey JK, Wold WSM, Rigden P: Thirty-one human adenovirus serotypes (Ad1-Ad31) form five groups (A-E) based upon DNA genome homologies. Virol 93:481-492, 1979
5. Graham FL: Transformation by and oncogenicity of human adenoviruses. In: Ginsberg HS (ed) The adenoviruses. Plenum Press, New York, 1984, pp 339-398
6. Trentin JJ, Yabe Y, Taylor G: Quest for human cancer viruses. Science 137:835-841, 1962
7. Shenk T, Flint J: Transcriptional and transforming activities of the adenovirus E1A proteins. Adv Cancer Res 57:47-85, 1991
8. Stillman B: Functions of the adenovirus E1B tumour antigens. Cancer Surv 5:389-404, 1986
9. Whyte P, Buchkovich KJ, Horowitz JM, Friend SH, Raybuck M, Weinberg RA, Harlow E: Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 334:82-85, 1988
10. Ewen ME, Xing YG, Lawrence JB, Livingston DM: Molecular cloning, chromosomal mapping, and expression of the cDNA for p107, a retinoblastoma gene product-related protein. Cell 66:1155-1164, 1991
11. Hannon GJ, Demetrick D, Beach D: Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins. Genes Dev 7:2378-2391, 1993
12. Bookstein R, Lee WH: Molecular genetics of the retinoblastoma suppressor gene. Crit Rev Oncog 2:211-227, 1991
13. Nevins JR, Chellappan SP, Mudryj M, Hiebert S, Devoto S, Horowitz J, Hunter T, Pines J: E2F transcription factor is a target for the RB protein and the cyclin A protein. Cold Spring Harb Symp Quant Biol 56:157-162, 1991
14. Pines J, Hunter T: Human cyclin A is adenovirus E1A-associated protein p60 and behaves differently from cyclin B. Nature 346:760-763, 1990
15. Tsai LH, Harlow E, Meyerson M: Isolation of the human cdk2 gene that encodes the cyclin A- and adenovirus E1A-associated p33 kinase. Nature 353: 174-177, 1991
16. Arany Z, Sellers W, Livingston DM, Eckner R: E1A-associated p300 and CREB-associated CBP belong to a conserved family of coactivators. Cell 77:799-800, 1994
17. Dyson N, Harlow E: Adenovirus E1A targets key regulators of cell proliferation. Cancer Surv 12: 161-195, 1992
18. Sarnow P, Ho YS, Williams J, Levine AJ: Adenovirus E1b 58kD tumor antigen and SV40 large tumor antigen are physically associated with the same 54kD cellular protein in transformed cells. Cell 28:387-394, 1982
19. Finlay CA, Hinds PW, Levine AJ: The p53 protooncogene can act as a suppressor of transformation. Cell 57:1083-1093, 1989
20. Fields S, Jang SK: Presence of a potent transcription activating sequence in the p53 protein. Science 249: 1046-1049, 1990
21. Raycroft L, Wu HY, Lozano G: Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene. Science 249:1049-1051, 1990
22. El Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825, 1993
23. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ: The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816, 1993
24. Yew PR, Berk AJ: Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein. Nature 357:82-85, 1992
25. Yew PR, Liu X, Berk AJ: Adenovirus E1B oncoprotein tethers a transcriptional repression domain to p53. Genes Dev 8:190-202, 1994
26. Ankerst J, Jonsson N, Kjellen L, Norrby E, Sjogren HO: Induction of mammary fibroadenomas in rats by adenovirus type 9. Int J Cancer 13:286-290, 1974
27. Javier R, Raska KJ, Macdonald GJ, Shenk T: Human adenovirus type 9-induced rat mammary tumors. J Virol 65:3192-3202, 1991
28. Brusca JS, Jannun R, Chinnadurai R: Efficient transformation of rat 3Y1 cells by human adenovirus type 9. Virology 136:328-337, 1984
29. Jannun R, Chinnadurai G: Functional relatedness between E1a and E1b regions of group C and group D human adenoviruses. Virus Res 7:33-48, 1987
30. Jonsson N, Ankerst J: Studies on adenovirus type 9-induced mammary fibroadenomas in rats and their malignant transformation. Cancer 39:2513-2519, 1977
31. Robbins SL, Angell M, Kumar V: Basic Pathology. W.B. Saunders, Philadelphia, 1981, pp 564-595
32. Rosai J: Ackerman's Surgical Pathology. Mosby, St. Louis, 1989, pp 1193-1267
33. Diaz NM, Palmer JO, McDivitt RW: Carcinoma arising within fibroadenomas of the breast. A clinico-pathologic study of 105 patients. Am J Clin Pathol 95:614-622, 1991
34. Mechtersheimer G, Kruger KH, Born IA, Moller P: Antigenic profile of mammary fibroadenoma and cystosarcoma phyllodes. A study using antibodies to estrogen- and progesterone receptors and to a panel of cell surface molecules. Pathol Res Pract 186:427-438, 1990
35. Koerner FC, O'Connell JX: Fibroadenoma: morphological observations and a theory of pathogenesis. Pathol Annu 1:1-19, 1994
36. Nandi S, McGrath CM: Mammary neoplasia in mice. Adv Cancer Res 17:353-414, 1973
37. Rose DP. In: Bulbrook RD, Taylor DJ (eds) Commentaries on Research in Breast Disease. Alan R. Liss, New York, 1979, pp 111-145
38. Ankerst J, Jonsson N: Adenovirus type 9-induced tumorigenesis in the rat mammary gland related to sex hormonal state. J Natl Cancer Inst 81:294-298, 1989
39. Meyer JE, Frenna TH, Polger M, Sonnenfeld MR, Shaffer K: Enlarging occult fibroadenomas. Radiology 183:639-641, 1992
40. Ansah BY, Tavassoli FA: Fibroadenoma and cystosarcoma phyllodes of the male breast. Mod Pathol 5:114-116, 1992
41. Tyler KL, Fields BN: Pathogenesis of viral infections. In: Fields BN (ed) Virology. Raven Press, New York, 1990, pp 191-239
42. Noguchi S, Motomura K, Inaji H, Imaoka S, Koyama H: Clonal analysis of fibroadenoma and phyllodes tumor of the breast. Cancer Res 53:4071-4074, 1993
43. Stephenson CF, Davis RI, Moore GE, Sandberg AA: Cytogenetic and fluorescence in situ hybridization analysis of breast fibroadenomas. Cancer Genet Cytogenet 63:32-36, 1992
44. Javier R, Raska KJ, Shenk T: Requirement for the adenovirus type 9 E4 region in production of mammary tumors. Science 257:1267-1271, 1992
45. Herisse J, Rigolet M, de Dinechin SD, Galibert F: Nucleotide sequence of adenovirus 2 DNA fragment encoding for the carboxylic region of fiber protein and the entire E4 region. Nucleic Acids Res 9:4023-4042, 1981
46. Hogenkamp T, Esche H: Nucleotide sequence of the right 10% of adenovirus type 12 DNA encoding the entire region E4. Nucleic Acids Res 18:3065-3066, 1990
47. Javier RT: Adenovirus type 9 E4 open reading frame 1 encodes a transforming protein required for the production of mammary tumors in rats. J Virol 68: 3917-3924, 1994